• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Mallinckrodt PLC

+ Add to Watchlist

MNK:US

89.3000 USD 2.1500 2.47%

As of 16:15:06 ET on 10/21/2014.

Snapshot for Mallinckrodt PLC (MNK)

Open: 87.8600 Day's Range: 87.5806 - 89.4900 Volume: 1,370,926
Previous Close: 87.1500 52wk Range: 41.6700 - 94.0100 1-Yr Rtn: +110.81%

Stock Chart for MNK

No chart data available.
  • MNK:US 89.3000
  • 1D
  • 1M
  • 1Y
87.1500
Interactive MNK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MNK

Current P/E Ratio (ttm) 33.7310
Estimated P/E(09/2014) 20.0449
Relative P/E vs. SPX 1.9777
Earnings Per Share (USD) (ttm) 2.6474
Est. EPS (USD) (09/2014) 4.4550
Est. PEG Ratio 0.8581
Market Cap (M USD) 10,152.84
Shares Outstanding (M) 113.69
30 Day Average Volume 2,082,318
Price/Book (mrq) 3.9367
Price/Sale (ttm) 2.2514
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth 0.00%
Next Earnings Announcement 11/19/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MNK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MNK

Mallinckrodt PLC develops, manufactures and markets specialty pharmaceutical products and diagnostic imaging agents. The Company specializes in the manufacturing of pain management medications. Mallinckrodt offers its products to major wholesalers and retail drug store chains around the world.

Mark C TrudeauPresident/CEOMatthew K HarbaughSenior VP/CFO
Ray FureySenior VP/Chief Compliance OfcrMario SaltarelliSenior VP/Chief Science Ofcr
More Company Profile & Key Executives for MNK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil